ASTH - NYC Investor Dinner Highlights Durable Execution Across Growth Initiatives

Research evidence excerpt

ASTH - NYC Investor Dinner Highlights Durable Execution Across Growth Initiatives

Wk Range $46.41-$18.16 open-source optionality. ASTH framed AI model selection around workflow complexity,

Market Cap ($M) $2,561 arguing that many administrative tasks have fixed thresholds where incremental frontier-

model improvement offers diminishing returns once quality is sufficient. Frontier models may ADTV 369,608

remain useful for complex tasks, but use cases such as chart reading, coding, diagnosis Shares Out (M) 55 support, claims agents, prior authorization, eligibility, voice, SMS, and physician-feedback

Short Interest Ratio/% Of Float 5.3% iteration do not necessarily require them indefinitely. The company noted that while open-

Dividend/Yield $0.00/0.0% source models lag frontier models by several months, they are improving quickly. ASTH

Enterprise Value ($M) $3,110 expects to use frontier models while costs are venture-subsidized, but could shift to open

Cash & Equivalents ($M) $478 source, potentially on its own infrastructure, if costs rise. The company also flagged that

Total Debt ($M) $1,028 AI lowers outreach costs, with roughly $0.10-per-minute outreach supporting a lower ROI

hurdle.

14 Page Document Prospect synergy capture remains on track; the larger opportunity is in MLR

improvement and recontracting execution. ASTH said the original $12-$15 mln G&A

synergy target remains in reach, with $15 mln attainable soon, but the company sees

Reasons for this report potentially larger opportunities outside G&A. These include COGS or MLR synergies from

moving Prospect trend closer to legacy Astrana levels, plus revenue synergies from RAF

✓ Management Meeting Takeaways improvement and payer recontracting. Prospect trend is already down approximately half a